Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial

Collapse authors list.
Mowat, Craig, Arnott, Ian, Cahill, Aiden, Smith, Malcolm, Ahmad, Tariq, Subramanian, Sreedhar ORCID: 0000-0002-6483-1730, Travis, Simon, Morris, John, Hamlin, John, Dhar, Anjan et al (show 34 more authors) , Nwokolo, Chuka, Edwards, Cathryn, Creed, Tom, Bloom, Stuart, Thomas, Linzi, Campbell, Simon, Lewis, Stephen J, Sebastian, Shaji, Sen, Sandip, Yousif, Mohamed, Lal, Simon, Hawkey, Chris, Murray, Charles, Cummings, Fraser, Goh, Jason, Lindsay, James O, Arebi, Naila, Potts, Lindsay, McKinley, Aileen J, Thomson, John M, Todd, John A, Collie, Mhairi, Dunlop, Malcolm G, Mowat, Ashley, Gaya, Daniel R, Winter, Jack, Naismith, Graham D, Ennis, Holly, Keerie, Catriona, Lewis, Steff, Prescott, Robin J, Kennedy, Nicholas A, Satsangi, Jack and Grp, TOPPIC Study (2016) Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial. LANCET GASTROENTEROLOGY & HEPATOLOGY, 1 (4). 273 - 282.

Access the full-text of this item by clicking on the Open Access link.

Item Type:	Article
Depositing User:	Symplectic Admin
Date Deposited:	28 Jan 2019 15:31
Last Modified:	25 Jan 2022 18:20
DOI:	10.1016/S2468-1253(16)30078-4
Open Access URL:	https://doi.org/10.1016/S2468-1253(16)30078-4
Related URLs:	Author
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3031914